Press Release
06/04/2025 Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.
Investors
08/05/2025 | Reporting
Report on 2nd quarter 2025: Earnings Release and Conference Call
You are interested in our news?
Order our news
Would you like to be included on our distribution list for our news? We would be happy to provide you with our latest press releases and short news by e-mail. This service is free of charge and may be cancelled at any time.
You can cancel this free service at any time by sending an e-mail to
ir(at)freseniusmedicalcare.com, or by calling +49 (0) 6172 268 87 95.
The information you provide will only be used to answer your query. For more information on how we process your Personal Data please read our
privacy policy.
In this section: